' Triple ' Screening for AAA, PAD, High BP Reduces Mortality ' Triple ' Screening for AAA, PAD, High BP Reduces Mortality

Results of the VIVA trial show that a program of three screening tests--for abdominal aortic aneurysm, peripheral arterial disease, and hypertension--resulted in a significant reduction in all-cause mortality at 5 years.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news